Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 78 articles:
HTML format



Single Articles


    July 2022
  1. WANG Y, Feng L, Zeng G, Zhu H, et al
    Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.
    Circulation. 2022;146:303-315.
    PubMed     Abstract available


  2. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed     Abstract available


  3. TREMBLAY E, Gosselin C, Mai V, Lajoie AC, et al
    Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2022 Jul 8:101161CIRCULATIONAHA121058635.
    PubMed     Abstract available


    May 2022
  4. BROOK RD, Scirica BM, Levy PD
    "The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension.
    Circulation. 2022;145:1629-1631.
    PubMed    


    March 2022
  5. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available


  6. STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
    Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
    Circulation. 2022;145:793-795.
    PubMed    


  7. KANDZARI DE, Mahfoud F, Weber MA, Townsend R, et al
    Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
    Circulation. 2022;145:847-863.
    PubMed     Abstract available


  8. LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
    Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
    PubMed     Abstract available


  9. NIENABER CA, Yuan X
    Taming Hypertension to Prevent Aortic Dissection: Universal Recognition of a "New Normal" Blood Pressure?
    Circulation. 2022;145:645-647.
    PubMed    


    February 2022
  10. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
    Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
    PubMed     Abstract available


  11. HONIGBERG MC, Zekavat SM, Raghu VK, Natarajan P, et al
    Microvascular Outcomes in Women With a History of Hypertension in Pregnancy.
    Circulation. 2022;145:552-554.
    PubMed    


  12. MACINTYRE IM, Turtle EJ, Farrah TE, Graham C, et al
    Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    Circulation. 2022;145:416-423.
    PubMed     Abstract available


  13. SMITH SM, Cooper-DeHoff RM
    Acetaminophen-Induced Hypertension: Where Have All the "Safe" Analgesics Gone?
    Circulation. 2022;145:424-426.
    PubMed    


    January 2022
  14. LAFFIN LJ, Kaufman HW, Chen Z, Niles JK, et al
    Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic.
    Circulation. 2022;145:235-237.
    PubMed    


    November 2021

  15. Correction to: National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021;144:e333.
    PubMed    


  16. NAEIJE R
    Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e328-e329.
    PubMed    


  17. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
    Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e330-e331.
    PubMed    


  18. HIBINO M, Otaki Y, Kobeissi E, Pan H, et al
    Blood Pressure, Hypertension and The Risk of Aortic Dissection Incidence and Mortality: results from the Japan-Specific Health Checkups Study, the UK Biobank Study and a Meta-analysis of Cohort Studies.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.056546.
    PubMed     Abstract available


  19. LU Y, Wang Y, Spatz ES, Onuma O, et al
    National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057056.
    PubMed    


    October 2021
  20. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available


  21. WEI J, Fang D
    Letter by Wei and Fang Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e236.
    PubMed    


  22. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Response by Filippini et al to Letter Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e237.
    PubMed    


    September 2021
  23. BLUMENTHAL JA, Hinderliter AL, Smith PJ, Mabe S, et al
    Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial.
    Circulation. 2021 Sep 27. doi: 10.1161/CIRCULATIONAHA.121.055329.
    PubMed    


  24. LEO F, Suvorava T, Heuser SK, Li J, et al
    Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure.
    Circulation. 2021;144:870-889.
    PubMed     Abstract available


    August 2021
  25. LEOPOLD JA
    Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.
    Circulation. 2021;144:556-558.
    PubMed    


    July 2021
  26. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    PubMed     Abstract available


    June 2021
  27. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    PubMed     Abstract available


  28. RAYNER BL, Spence JD
    Physiological Treatment of Hypertension in Black Patients: Time for Action.
    Circulation. 2021;143:2367-2369.
    PubMed    


  29. KAZI DS, Wei PC, Penko J, Bellows BK, et al
    Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value.
    Circulation. 2021;143:2406-2408.
    PubMed    


  30. JOSEPH JJ, Pohlman NK, Zhao S, Kline D, et al
    Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.
    Circulation. 2021;143:2355-2366.
    PubMed     Abstract available


  31. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    PubMed     Abstract available


  32. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    PubMed     Abstract available


    May 2021
  33. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    PubMed    


  34. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    PubMed    


  35. BROOK RD, Levy PD, Jamerson KA
    Mission "UnACCOMPLISHed": Optimal Antihypertensive Therapy.
    Circulation. 2021;143:1932-1934.
    PubMed    


  36. KARIO K, Ferdinand KC, Vongpatanasin W
    Are SGLT2 Inhibitors New Hypertension Drugs?
    Circulation. 2021;143:1750-1753.
    PubMed    


    April 2021
  37. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    PubMed     Abstract available


  38. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.
    Circulation. 2021;143:1542-1567.
    PubMed     Abstract available


  39. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    PubMed     Abstract available


  40. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available


    March 2021
  41. LI D, Shao NY, Moonen JR, Zhao Z, et al
    ALDH1A3 Coordinates Metabolism with Gene Regulation in Pulmonary Arterial Hypertension.
    Circulation. 2021 Mar 25. doi: 10.1161/CIRCULATIONAHA.120.048845.
    PubMed     Abstract available


  42. ZHU L, Liu F, Hao Q, Feng T, et al
    Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension.
    Circulation. 2021 Mar 4. doi: 10.1161/CIRCULATIONAHA.120.046542.
    PubMed     Abstract available


    February 2021
  43. KUEHN BM
    Rising Prepregnancy Hypertension, Preeclampsia Disparities Raise Alarm.
    Circulation. 2021;143:753-754.
    PubMed    


  44. SUDHARSANAN N, Theilmann M, Kirschbaum TK, Manne-Goehler J, et al
    Variation in the Proportion of Adults in Need of BP-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1,037,215 Individuals from 50 Nationally Representative Surveys.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.051620.
    PubMed     Abstract available


    January 2021
  45. MCEVOY JW
    Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e20-e21.
    PubMed    


  46. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
    Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e22-e23.
    PubMed    


    December 2020
  47. BOGUSLAVSKYI A, Tokar S, Prysyazhna O, Rudyk O, et al
    Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure and Hypertension in Mice and Man.
    Circulation. 2020 Dec 18. doi: 10.1161/CIRCULATIONAHA.119.040557.
    PubMed     Abstract available


    November 2020
  48. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
    Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
    PubMed    


  49. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    PubMed    


    October 2020

  50. Correction to: Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020;142:e235.
    PubMed    


  51. ZHANG DY, Cheng YB, Guo QH, Shan XL, et al
    Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Circulation. 2020 Oct 6. doi: 10.1161/CIRCULATIONAHA.120.046685.
    PubMed     Abstract available


  52. LACKLAND DT, Howard VJ, Cushman M, Oparil S, et al
    Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.
    Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.048063.
    PubMed    


    September 2020
  53. CUI C, Fan J, Zeng Q, Cai J, et al
    CD4(+) T-Cell Endogenous Cystathionine gamma Lyase-Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation.
    Circulation. 2020 Sep 9. doi: 10.1161/CIRCULATIONAHA.119.045344.
    PubMed     Abstract available


    August 2020
  54. HONIGBERG MC, Chaffin M, Aragam K, Bhatt DL, et al
    Genetic Variation in Cardiometabolic Traits and Medication Targets and the Risk of Hypertensive Disorders of Pregnancy.
    Circulation. 2020;142:711-713.
    PubMed    


    July 2020
  55. SHEN H, Zhang J, Wang C, Jain PP, et al
    MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 28. doi: 10.1161/CIRCULATIONAHA.120.048191.
    PubMed     Abstract available


  56. OMURA J, Habbout K, Shimauchi T, Wu WH, et al
    Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.047626.
    PubMed     Abstract available


  57. GUO C, Zeng Y, Chang LY, Yu Z, et al
    Independent and Opposing Associations of Habitual Exercise and Chronic PM2.5 Exposures on Hypertension Incidence.
    Circulation. 2020 Jul 20. doi: 10.1161/CIRCULATIONAHA.120.045915.
    PubMed    


  58. HAYNES N, Cooper LA, Albert MA
    At the Heart of the Matter: Unmasking and Addressing the Toll of COVID-19 on Diverse Populations.
    Circulation. 2020;142:105-107.
    PubMed    


    June 2020
  59. MESSERLI FH, Siontis GCM, Rexhaj E
    COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Circulation. 2020;141:2042-2044.
    PubMed    


  60. ERCU M, Marko L, Schachterle C, Tsvetkov D, et al
    Phosphodiesterase 3A and Arterial Hypertension.
    Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.043061.
    PubMed     Abstract available


  61. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed     Abstract available


    May 2020
  62. HOFFMANN F, Limper U, Zaha VG, Reuter H, et al
    Evolution of Pulmonary Hypertension During Severe Sustained Hypoxia.
    Circulation. 2020;141:1504-1506.
    PubMed    


    April 2020
  63. FULTON DJR, Stepp DW
    Origins of Hypertension in Obesity: Plain Vanilla(oid) or Multiple Flavors?
    Circulation. 2020;141:1334-1337.
    PubMed    


  64. SIEDLINSKI M, Jozefczuk E, Xu X, Teumer A, et al
    White Blood Cells and Blood Pressure: A Mendelian Randomization Study.
    Circulation. 2020;141:1307-1317.
    PubMed     Abstract available


  65. OTTOLINI M, Hong K, Cope EL, Daneva Z, et al
    Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.
    Circulation. 2020;141:1318-1333.
    PubMed     Abstract available


  66. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    PubMed    


    March 2020
  67. WHITE WB, Wolfson L
    Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e652-e653.
    PubMed    


  68. RIVASI G, Mossello E, Ungar A
    Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e650-e651.
    PubMed    


  69. JEFFERSON AL
    Midlife Consequences of Cumulative Blood Pressure Exposure: Importance of a Lifespan Approach.
    Circulation. 2020;141:725-727.
    PubMed    


  70. SCHIMMEL K, Jung M, Foinquinos A, Jose GS, et al
    Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
    Circulation. 2020;141:751-767.
    PubMed     Abstract available


  71. MAHINRAD S, Kurian S, Garner CR, Sedaghat S, et al
    Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife.
    Circulation. 2020;141:712-724.
    PubMed     Abstract available


    February 2020
  72. KAYE DM, Shihata W, Jama HA, Tsyganov K, et al
    Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.
    Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081.
    PubMed     Abstract available


  73. JACKEVICIUS CA, Krumholz HM, Chong A, Koh M, et al
    Population Impact of Generic Valsartan Recall.
    Circulation. 2020;141:411-413.
    PubMed    


    January 2020
  74. AGDAMAG AC, Krishnappa D, Benditt DG
    ST-Segment Changes After Loss of Consciousness.
    Circulation. 2020;141:80-82.
    PubMed    


    December 2019
  75. GRANDI SM, Smith GN, Platt RW
    The Relative Contribution of Pregnancy Complications to Cardiovascular Risk Prediction: Are We Getting It Wrong?
    Circulation. 2019;140:1965-1967.
    PubMed    


    November 2019
  76. TONG D, Schiattarella GG, Jiang N, May HI, et al
    Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1769-1771.
    PubMed    


    October 2019
  77. DIAZ R, Tajer C
    Current Status and Future Strategies for Cardiovascular Disease in Argentina.
    Circulation. 2019;140:1137-1139.
    PubMed    


    July 2019
  78. STRANDBERG TE
    Blood Pressure in a 100-Year Perspective.
    Circulation. 2019;140:101-102.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: